Market Cap 21.89B
Revenue (ttm) 13.01B
Net Income (ttm) 746.00M
EPS (ttm) N/A
PE Ratio 17.18
Forward PE 15.96
Profit Margin 5.73%
Debt to Equity Ratio 0.60
Volume 566,200
Avg Vol 760,390
Day's Range N/A - N/A
Shares Out 83.70M
Stochastic %K 43%
Beta 0.78
Analysts Strong Sell
Price Target $293.41

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 336 229 1127
Address:
358 South Main Street, Burlington, United States
ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 3:30 PM
UBS has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Buy with a target price of 282 → 305.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 1:50 PM
Evercore ISI Group updates rating for Labcorp Hldgs ( $LH ) to Outperform, target set at 285 → 300.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 1:00 PM
Morgan Stanley has updated their rating for Labcorp Hldgs ( $LH ) to Overweight with a price target of 306.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 12:00 PM
Baird has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Outperform with a target price of 290 → 302.
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 24 at 6:39 PM
Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330 $LH $VTI $VOO https://stocktwits.com/news/equity/markets/labcorp-raises-full-year-guidance-after-q2-earnings-beat-wall-street-expectations/ch8z5pVR5HC
0 · Reply
topstockalerts
topstockalerts Jul. 24 at 5:55 PM
$LH trying to consolidate here..
0 · Reply
ZacksResearch
ZacksResearch Jul. 24 at 5:08 PM
$LH just crushed Q2 — here’s what’s fueling the move 🚀 Double-digit EPS growth, margin expansion, and a raised 2025 outlook pushed the stock higher in pre-market. Full breakdown here 👉 https://www.zacks.com/stock/news/2612878/labcorp-q2-earnings-revenues-beat-estimates-stock-up-in-pre-market?cid=sm-stocktwits-2-2612878-teaser-3720&ADID=SYND_STOCKTWITS_TWEET_2_2612878_TEASER_3720
0 · Reply
schaeffers
schaeffers Jul. 24 at 5:03 PM
$LH is spiking! Up nearly 9% after a strong earnings beat and raised profit forecast & leading $SPX. It smashed thru resistance at $260$265 level and clocked a record high $283.47 out of the gate today, pacing for its best day since Aug. 2024. Now +16.8% YTD. 📈📈
0 · Reply
TalkMarkets
TalkMarkets Jul. 24 at 4:37 PM
#Nasdaq, S&P 500 Notch More Records; #Dow Gaps Lower $DOW $LH $LVS $QQQ $SPX https://talkmarkets.com/content/us-markets/nasdaq-sp-500-notch-more-records-dow-gaps-lower?post=511261
0 · Reply
Latest News on LH
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 2:38 PM EDT - 11 days ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript


Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 12:27 PM EDT - 11 days ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?


Labcorp Announces 2025 Second Quarter Results

Jul 24, 2025, 6:50 AM EDT - 11 days ago

Labcorp Announces 2025 Second Quarter Results


Labcorp Declares Quarterly Dividend

Jul 10, 2025, 6:50 AM EDT - 25 days ago

Labcorp Declares Quarterly Dividend


Labcorp to Webcast Its Annual Meeting of Shareholders May 15

May 8, 2025, 4:15 PM EDT - 3 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15


Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:21 PM EDT - 3 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript


Labcorp Announces 2025 First Quarter Results

Apr 29, 2025, 6:50 AM EDT - 3 months ago

Labcorp Announces 2025 First Quarter Results


Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 3:42 PM EST - 6 months ago

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript


Labcorp Announces 2024 Fourth Quarter and Full Year Results

Feb 6, 2025, 6:50 AM EST - 6 months ago

Labcorp Announces 2024 Fourth Quarter and Full Year Results


LABCORP DECLARES QUARTERLY DIVIDEND

Jan 8, 2025, 6:02 PM EST - 7 months ago

LABCORP DECLARES QUARTERLY DIVIDEND


Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Nov 19, 2024, 7:00 AM EST - 9 months ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

ONC


Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 2:00 PM EDT - 10 months ago

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript


Labcorp beats quarterly estimates on diagnostic test demand

Oct 24, 2024, 7:10 AM EDT - 10 months ago

Labcorp beats quarterly estimates on diagnostic test demand


Labcorp Announces 2024 Third Quarter Results

Oct 24, 2024, 6:50 AM EDT - 10 months ago

Labcorp Announces 2024 Third Quarter Results


CommonWell Health Alliance Welcomes Labcorp as Newest Member

Sep 18, 2024, 9:00 AM EDT - 11 months ago

CommonWell Health Alliance Welcomes Labcorp as Newest Member


ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 3:30 PM
UBS has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Buy with a target price of 282 → 305.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 1:50 PM
Evercore ISI Group updates rating for Labcorp Hldgs ( $LH ) to Outperform, target set at 285 → 300.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 1:00 PM
Morgan Stanley has updated their rating for Labcorp Hldgs ( $LH ) to Overweight with a price target of 306.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 12:00 PM
Baird has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Outperform with a target price of 290 → 302.
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 24 at 6:39 PM
Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330 $LH $VTI $VOO https://stocktwits.com/news/equity/markets/labcorp-raises-full-year-guidance-after-q2-earnings-beat-wall-street-expectations/ch8z5pVR5HC
0 · Reply
topstockalerts
topstockalerts Jul. 24 at 5:55 PM
$LH trying to consolidate here..
0 · Reply
ZacksResearch
ZacksResearch Jul. 24 at 5:08 PM
$LH just crushed Q2 — here’s what’s fueling the move 🚀 Double-digit EPS growth, margin expansion, and a raised 2025 outlook pushed the stock higher in pre-market. Full breakdown here 👉 https://www.zacks.com/stock/news/2612878/labcorp-q2-earnings-revenues-beat-estimates-stock-up-in-pre-market?cid=sm-stocktwits-2-2612878-teaser-3720&ADID=SYND_STOCKTWITS_TWEET_2_2612878_TEASER_3720
0 · Reply
schaeffers
schaeffers Jul. 24 at 5:03 PM
$LH is spiking! Up nearly 9% after a strong earnings beat and raised profit forecast & leading $SPX. It smashed thru resistance at $260$265 level and clocked a record high $283.47 out of the gate today, pacing for its best day since Aug. 2024. Now +16.8% YTD. 📈📈
0 · Reply
TalkMarkets
TalkMarkets Jul. 24 at 4:37 PM
#Nasdaq, S&P 500 Notch More Records; #Dow Gaps Lower $DOW $LH $LVS $QQQ $SPX https://talkmarkets.com/content/us-markets/nasdaq-sp-500-notch-more-records-dow-gaps-lower?post=511261
0 · Reply
ZacksResearch
ZacksResearch Jul. 24 at 3:25 PM
$LH beats earnings and raises guidance 📈 Labcorp's Q2 adjusted EPS of $4.35 beat the Zacks Consensus Estimate by 5.07%, with revenues up 9.5% year over year. The company also lifted its 2025 revenue and EPS outlook, primarily driven by currency and underlying business strength. See why LH could be a stock to watch 👉 https://www.zacks.com/stock/news/2612878/labcorp-q2-earnings-revenues-beat-estimates-stock-up-in-pre-market?cid=sm-stocktwits-2-2612878-body-3624&ADID=SYND_STOCKTWITS_TWEET_2_2612878_BODY_3624
0 · Reply
Jamtrades
Jamtrades Jul. 24 at 2:07 PM
$LH looks good to $330 $SPY
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 10:55 AM
$LH Labcorp reports Q2 adjusted EPS $4.35, consensus $4.16 -- Q2 revenue $3.53B, consensus $3.49B.
0 · Reply
ZacksResearch
ZacksResearch Jul. 21 at 1:01 PM
$LH set to report Q2 earnings — will it keep the surprise streak alive? 🤔 Labcorp has beaten estimates in the last four quarters, with a solid 2.31% average surprise. This time, EPS is expected to rise 5.1% to $4.14, with revenues pegged at $3.49B, an 8.3% increase from the year-ago reported figure. Explore the full earnings preview here 👉 https://www.zacks.com/stock/news/2599188/labcorp-q2-earnings-preview-diagnostics-strength-in-focus?cid=sm-stocktwits-2-2599188-body-2760&ADID=SYND_STOCKTWITS_TWEET_2_2599188_BODY_2760
0 · Reply
ZacksResearch
ZacksResearch Jul. 21 at 11:46 AM
$LH Q2 setup looks strong — but will diagnostics carry the quarter? Momentum in diagnostics, plus key acquisitions and new biomarker tests, are expected to drive revenue growth. Full earnings preview here 👉 https://www.zacks.com/stock/news/2599188/labcorp-q2-earnings-preview-diagnostics-strength-in-focus?cid=sm-stocktwits-2-2599188-teaser-2720&ADID=SYND_STOCKTWITS_TWEET_2_2599188_TEASER_2720
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
Evercore ISI Group has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Outperform with a target price of 260 → 285.
0 · Reply
Estimize
Estimize Jul. 8 at 12:03 PM
Wall St is expecting 4.18 EPS for $LH Q2 [Reporting 07/24 BMO] http://www.estimize.com/intro/lh?chart=historical&metric_name=eps&utm_conten
0 · Reply
JarvisFlow
JarvisFlow Jun. 25 at 1:56 PM
Barclays has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Equal-Weight with a target price of 250 → 275.
0 · Reply
Estimize
Estimize Jun. 23 at 12:03 PM
Wall St is expecting 4.18 EPS for $LH Q2 [Reporting 07/31 BMO] http://www.estimize.com/intro/lh?chart=historical&metric_name=eps&utm_conten
0 · Reply
ZacksResearch
ZacksResearch Jun. 18 at 1:10 PM
$LH up 25.6% over the past year, outperforming the industry's 16.2% fall and S&P 500's 9.1% gain — what's driving this rally? 🚀 Labcorp's strategic acquisitions, enhanced neurodegenerative testing, and LaunchPad savings initiatives are fueling growth. Plus, their solid cash position and no short-term debt add financial strength. Discover Labcorp's growth strategy here 👉 https://www.zacks.com/commentary/2510266/labcorp-stock-climbs-256-this-year-whats-driving-the-surge?cid=sm-stocktwits-2-2510266-body&ADID=SYND_STOCKTWITS_TWEET_2_2510266_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 18 at 11:34 AM
$LH up 25.6% YTD — what’s fueling the rally? Specialty testing is gaining momentum, recent acquisitions are clicking, and financials are holding strong. See what’s behind the move 👉 https://www.zacks.com/stock/news/2510266/labcorp-stock-climbs-256-this-year-whats-driving-the-surge?cid=sm-stocktwits-2-2510266-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2510266_TEASER
0 · Reply
MHM7700
MHM7700 Jun. 12 at 1:49 PM
$TSLA – Attempting Recovery After Breakdown Key Resistance: $325.08 → $326.48 → $329.00 Support Levels: $321.54 → $318.13 → $315.25 Technical Summary: • Breakdown from lower high ($LH) structure led to extended selling into $318. • EMAs are bearishly stacked; price below VWAP and anchored supply zone. • Volume surge on morning bounce into $323.40, but struggling under supply. • RSI still under neutral zone. Structure Note: Oversold bounce from $318 zone. Sellers stepped back in under $325.08. Now testing supply-to-neutral transition. Bullish Plan: Above $323.40 with volume → Reclaim $325.08 and squeeze to $326.48 Over $326.48 → Full retrace to $329 possible Bearish Plan: Failure at $323.40 → Rejection zone opens path toward $321.54 and $318 Under $318 = trigger short toward $315.25 on trend continuation Needs strong reclaim of $325.08 to flip momentum. Otherwise, sellers remain in control below $323.
0 · Reply